EURICAN PUPPY DAP LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE
EURICAN PUPPY DAP LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE
Authorised
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Canine adenovirus 2, strain DK13, Live
Product identification
Medicine name:
EURICAN PUPPY DAP LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE
Active substance:
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Canine adenovirus 2, strain DK13, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain BA5, Live4.00/log10 (50% cell culture infectious dose)/dose1.00Dose
-
Canine parvovirus, strain CAG2, Live4.90/log10 (50% cell culture infectious dose)/dose1.00Dose
-
Canine adenovirus 2, strain DK13, Live2.50/log10 (50% cell culture infectious dose)/dose1.00Dose
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1216457 8/2023
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 8/01/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025